We serve Carbobenzoxy-D-Val-D-Met CAS:108543-82-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Carbobenzoxy-D-Val-D-Met
CAS.NO: 108543-82-4
Molecular Formula:C18H26N2O5S
Molecular Weight:382.47400
Synonyms:
z-val-met-oh
Physical and Chemical Properties:
Density: /
Boiling point: /
Melting point: 179-181 ° C
Flash point:/
Refractive index: /
Specification:
Appearance: White Crystalline Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like Carbobenzoxy-D-Val-D-Met chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,z-val-met-oh physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,z-val-met-oh Use and application,z-val-met-oh technical grade,usp/ep/jp grade.
Related News: It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305.4-Bromoisoquinoline manufacturer Chinese President Xi Jinping vowed to tackle the spread of the virus, saying: “People’s lives and health should be given top priority and the spread of the outbreak should be resolutely curbed.”[S-(R*,R*)]- 2,2,2-Trifluoro-N-(1-oxiranyl-2-phenylethyl)acetamide supplier Chinese President Xi Jinping vowed to tackle the spread of the virus, saying: “People’s lives and health should be given top priority and the spread of the outbreak should be resolutely curbed.”DL-Glutamic Acid vendor Microarrays of over 5,500 plasma membrane and secreted protein targets are expressed in human cells.Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.
